VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AVTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AVTXAvalo Therapeutics, Inc.
$15.30$667M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAVTXQuarterly Balance Sheet

Avalo Therapeutics, Inc. (AVTX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Avalo Therapeutics, Inc. (AVTX) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

AVTX Balance Sheet

Quarterly statement

AVTX Balance Sheet

Avalo Therapeutics, Inc. (AVTX) balance sheet — 14-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets407.93M88.83M105.29M113.85M115.19M126.94M138.89M86.15M95.89M111.21M8.39M12.66M7.52M19.25M16.42M19.45M15.02M43.66M61.84M77.01M
Cash & Short-Term Investments400.28M81.99M98.34M111.62M113.26M125.05M134.55M81.86M93.43M110.18M7.42M10.18M6.31M16.69M13.17M16.94M11.25M38.47M54.59M71.51M
Cash Only85.38M24.99M15.86M26.96M42.29M125.05M134.55M81.86M93.43M110.18M7.42M10.18M6.31M16.69M13.17M16.94M11.25M38.47M54.59M71.51M
Short-Term Investments314.89M57.01M82.48M84.65M70.97M000000000000000
Accounts Receivable000000611K998K33K35K136K1.54M44K857K1.92M1.31M1.85M2.38M4.8M3.91M
Days Sales Outstanding------385.49190.47--134.86308.3663.76262.99165.989.74186.45275.521.83K307.69
Inventory00000000000018K19K20K22K23K25K38K16K
Days Inventory Outstanding------------2.380.353.123.921.393.940.281.82
Other Current Assets49K147K6.95M90K20K62K3.73M3.29M2.44M1M844K941K1.15M1.69M1.3M53K14K100K51K164K
Total Non-Current Assets82.85M11.06M11.17M11.25M11.4M11.58M11.84M12.31M12.41M12.52M12.6M16.61M16.72M16.98M16.95M17.1M17.2M18.24M18.37M18.35M
Property, Plant & Equipment288K375K460K542K686K949K1.21M1.67M1.78M1.88M1.97M2.07M2.18M2.44M2.41M2.51M2.57M2.6M2.69M1.41M
Fixed Asset Turnover--0.12x---0.13x0.14x--0.28x0.11x0.28x0.20x0.36x5.89x0.40x0.44x0.11x0.95x
Goodwill10.5M10.5M10.5M10.5M10.5M10.5M10.5M10.5M10.5M10.5M10.5M14.41M14.41M14.41M14.41M14.41M14.41M14.41M14.41M14.41M
Intangible Assets00000000000000000038K304K
Long-Term Investments71.88M0000000000000131K00000
Other Non-Current Assets183K183K210K210K210K131K131K131K131K131K131K131K131K131K131K181K227K1.23M1.23M2.23M
Total Assets490.78M99.89M116.46M125.1M126.58M138.52M150.73M98.45M108.31M123.73M20.99M29.27M24.23M36.23M33.37M36.55M32.22M61.9M80.21M95.36M
Asset Turnover--0.00x---0.00x0.00x--0.02x0.01x0.02x0.01x0.03x0.43x0.02x0.02x0.00x0.02x
Asset Growth %287.72%-27.89%-22.74%27.06%16.87%11.96%618.01%236.37%346.9%241.46%-37.08%-19.91%-24.79%-41.46%-58.4%-61.67%-49.72%-2.28%83.33%61.11%
Total Current Liabilities21.13M11.6M12.94M7.97M9.26M5.62M6.96M60.67M96.4M215.7M4.62M6M22.45M23.25M22.11M18.15M15.39M17.89M19.89M19.04M
Accounts Payable3.35M356K137K474K2.37M681K283K1.81M654K916K446K789K751K5.57M2.88M1.45M2.16M3.76M3.37M3.57M
Days Payables Outstanding-1.3K-13.0813.017.341.11K-158.81208.27-774.64-257.06295.17405.976.28321.18314.59171.92445.3836.43381.63
Short-Term Debt0328K000000000014.12M9.3M5.93M2.56M0000
Deferred Revenue (Current)0000000000000111K88K442K0000
Other Current Liabilities2.81M10.91M12.41M3.38M2.51M2.13M3.24M54.02M90.27M208.15M580K449K527K2.14M9.98M2.98M3.33M4.78M4.32M3.46M
Current Ratio19.31x7.66x8.14x14.28x12.44x22.61x19.96x1.42x0.99x0.52x1.82x2.11x0.33x0.83x0.74x1.07x0.98x2.44x3.11x4.04x
Quick Ratio19.31x7.66x8.14x14.28x12.44x22.61x19.96x1.42x0.99x0.52x1.82x2.11x0.33x0.83x0.74x1.07x0.97x2.44x3.11x4.04x
Cash Conversion Cycle-------------339.77187.06-152.09-300.9415.92-165.911.79K-72.12
Total Non-Current Liabilities20.99M19.97M20.47M25.58M12.75M10.29M10.74M16.7M25.52M9.11M9.07M8.57M8.75M19.26M22.17M20.43M22.78M37.66M37.24M36.01M
Long-Term Debt02M2M000000000010.47M13.49M16.5M18.71M33.18M32.83M32.48M
Capital Lease Obligations0035K117K197K275K00000000000000
Deferred Tax Liabilities463K446K434K304K293K278K270K154K168K162K155K164K156K148K141K133K128K122K113K130K
Other Non-Current Liabilities20.53M17.52M18M25.16M12.26M9.74M10.47M16.55M25.35M8.95M8.92M8.41M8.59M8.64M8.54M3.79M3.94M4.36M4.3M3.4M
Total Liabilities42.12M31.57M33.41M33.55M22.01M15.91M17.7M77.38M121.92M224.81M13.69M14.57M31.2M42.5M44.28M38.58M38.17M55.56M57.13M55.05M
Total Debt242K2.33M2.43M555K679K801K568K550K548K545K537K536K14.65M20.3M19.95M19.59M19.24M33.7M33.32M32.7M
Net Debt-85.14M-22.66M-13.43M-26.41M-41.61M-124.25M-133.98M-81.31M-92.88M-109.63M-6.88M-9.64M8.34M3.61M6.78M2.65M7.99M-4.76M-21.27M-38.8M
Debt / Equity0.00x0.03x0.03x0.01x0.01x0.01x0.00x0.03x--0.07x0.04x-----5.31x1.44x0.81x
Debt / EBITDA---------------4.74x----
Net Debt / EBITDA---------------0.64x----
Interest Coverage------------2.41x-7.18x-9.26x-9.33x4.56x-10.25x-17.86x-15.17x-16.73x
Total Equity448.66M68.32M83.05M91.55M104.57M122.61M133.03M21.08M-13.61M-101.08M7.3M14.7M-6.97M-6.27M-10.91M-2.03M-5.95M6.34M23.08M40.31M
Equity Growth %329.04%-44.28%-37.57%334.37%868.47%221.3%1721.36%43.42%-95.26%-1512.97%166.92%824.61%-17.11%-198.8%-147.29%-105.03%-127.57%-80.87%-6.03%4.52%
Book Value per Share10.293.404.496.549.6611.6612.701.95-1.78-117.639.1175.42-119.71-128.30-278.09-51.70-151.93161.96582.451155.22
Total Shareholders' Equity448.66M68.32M83.05M91.55M104.57M122.61M133.03M21.08M-13.61M-101.08M7.3M14.7M-6.97M-6.27M-10.91M-2.03M-5.95M6.34M23.08M40.31M
Common Stock53K25K18K18K11K11K10K10K1K1K1K192K14K13K9K9K9K113K9K112K
Retained Earnings-504.51M-468.15M-448.52M-434.8M-404.18M-383.41M-370.26M-334.92M-357.96M-456.42M-335.13M-326.97M-321.74M-313.78M-303.82M-294.01M-297.2M-284.22M-262.17M-242.97M
Treasury Stock00000000000000000000
Accumulated OCI-583K-6K68K41K-34K000000000000000
Minority Interest00000000000000000000